Tirzepatide vs Semaglutide: Which Weight Loss Medication Is Right for You?

Weight Loss & Metabolic Health
January 28, 2026

Medically reviewed by Susana Querido, MD – Triple Board-Certified in Family Medicine, Aesthetic Medicine, and Anti-Aging & Regenerative Medicine. Medical Director, Greenwich MD.

Tirzepatide vs Semaglutide: Expert Comparison

If you’re considering medical weight loss, you’ve likely heard about Tirzepatide and Semaglutide—two of the most effective prescription medications for sustainable weight loss. But which one is right for you?

At Greenwich MD, triple board-certified Dr. Susana Querido helps patients navigate this decision with personalized medical guidance based on your unique health profile, weight loss goals, and medical history.

Quick Comparison:

Feature	Semaglutide	Tirzepatide
Mechanism	GLP-1 agonist	GLP-1 + GIP dual agonist
Average Weight Loss	10-15% body weight	15-22% body weight
FDA Approved	Yes (2021)	Yes (2022)
Injection Frequency	Once weekly	Once weekly
Provider at Greenwich MD	Triple board-certified physician

Schedule Consultation | Call (203) 542-5606

Understanding the Basics

What is Semaglutide?

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist that mimics a natural hormone your body produces after eating. It works by:

Slowing stomach emptying to help you feel full longer
Reducing appetite and food cravings
Regulating blood sugar levels
Supporting sustainable weight loss

What is Tirzepatide?

Tirzepatide is a dual GIP/GLP-1 receptor agonist—the first medication to target both hormone pathways simultaneously. It works by:

Activating both GLP-1 and GIP receptors for enhanced effect
Significantly reducing appetite
Improving insulin sensitivity
Promoting substantial weight loss

Key Differences

Mechanism of Action

Feature	Semaglutide	Tirzepatide
Pathway	Single GLP-1 pathway	Dual GLP-1 + GIP pathways
Mechanism	Well-established mechanism	Enhanced insulin response
Clinical Data	Extensive clinical data	Potentially greater effect

Why This Matters: The dual-action of Tirzepatide may lead to greater weight loss in clinical trials, but individual responses vary. Dr. Querido evaluates which mechanism best suits your metabolic profile.

Weight Loss Results: Clinical Trial Data

Metric	Semaglutide	Tirzepatide
Average Weight Loss	10-15% body weight over 68 weeks	15-22% body weight over 72 weeks
Clinical Trial	STEP trials	SURMOUNT trials
Average Pounds Lost	33-35 pounds	48-52 pounds (highest dose)
Participants Losing ≥15% Body Weight	~50%	~57-63%

Important Context:

Individual results vary significantly
Both require lifestyle modifications
Dr. Querido creates personalized protocols combining medication with nutrition guidance

Dosing and Administration

Feature	Semaglutide	Tirzepatide
Administration	Subcutaneous injection once weekly	Subcutaneous injection once weekly
Schedule	Same day each week	Same day each week
Injection Sites	Abdomen, thigh, or upper arm	Abdomen, thigh, or upper arm
Starting Dose	0.25 mg weekly	2.5 mg weekly
Maintenance Dose	1.7-2.4 mg weekly	10-15 mg weekly
Time to Therapeutic Dose	16-20 weeks	20-24 weeks
Dose Escalation	Gradual	Gradual

Learn More:

Side Effects Comparison

Both medications have similar side effect profiles

Side Effect Category	Details
Common Side Effects	• Nausea (most common, usually temporary) • Diarrhea or constipation • Decreased appetite • Abdominal discomfort • Fatigue • Headache
How Dr. Querido Minimizes Side Effects	• Slow dose titration • Dietary recommendations • Timing adjustments • Anti-nausea support if needed • Regular monitoring
Serious Side Effects (Rare)	• Thyroid C-cell tumors (contraindicated with certain histories) • Pancreatitis risk • Gallbladder problems • Kidney issues • Severe allergic reactions

Why Physician Oversight Matters: Dr. Querido ensures thorough screening, appropriate dosing, and close monitoring throughout treatment.

Cost Considerations

Investment Includes:

Triple board-certified physician oversight
Personalized treatment plans
Nutritional guidance
Regular monitoring and adjustments
Comprehensive program support
Medical expertise

Contact us for pricing: (203) 542-5606

Which One Is Right for You?

The best medication depends on your individual circumstances. Dr. Querido evaluates:

Decision Guide: Choosing Between Semaglutide and Tirzepatide

Consider Semaglutide If:	Consider Tirzepatide If:
You want well-established medication with longer track record	You want potentially higher weight loss from clinical trials
You have 30-50+ pounds to lose	You have 50+ pounds to lose
You prefer proven long-term safety data	You want dual-mechanism medication (GLP-1 + GIP)
Cost is a consideration [IF PRICE DIFFERENCE]	Previous GLP-1 medications haven’t achieved desired results
You respond well to GLP-1 agonists	You’re comfortable with newer medication (FDA-approved)

Dr. Querido Evaluates:

Health Factors	Personal Circumstances
Type 2 diabetes status	Weight loss goals and timeline
Cardiovascular health	Lifestyle and activity level
Kidney and thyroid function	Budget considerations
Previous medication responses	Previous weight loss attempts
Medical contraindications	Support system